LRP5 and breast cancer: We therefore investigated the effects of LRP5-overexpressing osteocyte-derived CM on the expression of proteins associated with tumor progression (e.g., MMP9, Snail, cleaved caspase-3, IL-6, TGF-β1) and on breast cancer cell proliferation, migration, and invasion of tumor cells [23].